Multi-omics analysis reveals the prognostic value and immunomodulatory role of CTSW in breast cancer.

Further investigation of CTSW expression across the SCMOD2 molecular subtypes of breast cancer revealed a decreasing trend from Basal-like to HER2-E, Luminal A, and Luminal B subtypes in both RNA-seq and DNA microarray datasets (Fig. 3 A).

also in 47,180 other papers